Showing 1 - 20 results of 70 for search 'Funda Meriç Bernstam', query time: 0.04s
Refine Results
-
1
BREAST CONSERVING SURGERY IN LOCALLY ADVANCED BREAST CANCER by Funda Meriç Bernstam
Published 2006-01-01
Article -
2
SENTINEL LYMPH NODE DISSECTION CONTROVERSIES by Funda Meriç Bernstam
Published 2005-01-01
Article -
3
-
4
Whole Genome Sequencing in Cancer Clinics by Ken Chen, Funda Meric-Bernstam
Published 2015-01-01
Article -
5
-
6
Antibody-drug conjugates in lung cancer: dawn of a new era? by Niamh Coleman, Timothy A. Yap, John V. Heymach, Funda Meric-Bernstam, Xiuning Le
Published 2023-01-01
Article -
7
CanDrA: cancer-specific driver missense mutation annotation with optimized features. by Yong Mao, Han Chen, Han Liang, Funda Meric-Bernstam, Gordon B Mills, Ken Chen
Published 2013-01-01
Article -
8
-
9
-
10
-
11
397 Intra-tumor immunotherapy injections utilizing image guidance in interventional radiology: clinical trial experience at a tertiary care cancer center by Sanjay Gupta, Vivek Subbiah, Sapna Patel, Adi Diab, Ravi Murthy, Aung Naing, Funda Meric-Bernstam, Filip Janku, Alda Tam, Timothy Yap, Rahul Sheth
Published 2020-11-01Article -
12
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers by Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michal Marczyk, Naing Lin Shan, Kim Blenman, Uwe Holtrich, Kevin Kalinsky, Funda Meric-Bernstam, Lajos Pusztai
Published 2022-11-01
Article -
13
Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition by Niamh Coleman, Vivek Subbiah, Shubham Pant, Keyur Patel, Sinchita Roy-Chowdhuri, Sireesha Yedururi, Amber Johnson, Timothy A. Yap, Jordi Rodon, Kenna Shaw, Funda Meric-Bernstam
Published 2021-12-01
Article -
14
-
15
143 Correlating RNA-seq detection and IHC staining of potential antibody-drug conjugate (ADC) targets: HER3, HER2, TROP2, Nectin4, and aFLR by Funda Meric-Bernstam, Nathan Fowler, Ekaterina Postovalova, Zhongmin Xiang, Krystle Nomie, Vladimir Kushnarev, Alexander Bagaev, Danil Stupichev, Kirill Kryukov, Suren Davitavyan, Monique Johnson, Basavaraja Uddajjara Shanthappa
Published 2023-11-01Article -
16
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer by Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven Sherman, Maria Cabanillas, Mimi Hu, Luz E. Castellanos, Behrang Amini, Funda Meric-Bernstam, Tao Shen, Jie Wu
Published 2024-03-01
Article -
17
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials by Roman Groisberg, David S. Hong, Amini Behrang, Kenneth Hess, Filip Janku, Sarina Piha-Paul, Aung Naing, Siqing Fu, Robert Benjamin, Shreyaskumar Patel, Neeta Somaiah, Anthony Conley, Funda Meric-Bernstam, Vivek Subbiah
Published 2017-12-01
Article -
18
584 Phase I/II study to evaluate the safety and tolerability of avelumab in combination with other anti-cancer therapies in patients with advanced malignancies by Aung Naing, Funda Meric-Bernstam, Shubham Pant, Milind Javle, Juhee Song, Anas Alshawa, Bettzy Stephen, Abdulrazzak Zarifa, Jordi Rodon, Yali Yang, Robert A Wolff, Anne Knisely, Van Morris, Jibran Ahmed
Published 2023-11-01Article -
19
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials by Jeffrey A. How, Amir A. Jazaeri, Siqing Fu, Jordi Rodon Ahnert, Jing Gong, Bettzy Stephen, Hanna Ferreira Dalla Pria, Priya Bhosale, Amber Johnson, Ying Yuan, Funda Meric-Bernstam, Aung Naing
Published 2022-07-01
Article -
20
Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors by Niamh Coleman, Bettzy Stephen, Siqing Fu, Daniel Karp, Vivek Subbiah, Jordi Rodon Ahnert, Sarina A. Piha‐Paul, John Wright, Senait N. Fessahaye, Fengying Ouyang, Bulent Yilmaz, Funda Meric‐Bernstam, Aung Naing
Published 2024-02-01
Article